Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RBM27-POU4F3 readthrough (RBM27-POU4F3)
- Target
- RBM27-POU4F3
- Molecular classification
- Other (readthrough transcript between RNA-binding protein and transcription factor genes)
01
Overview
RBM27-POU4F3 readthrough is a naturally occurring transcript that joins the neighboring RBM27 and POU4F3 genes[1]. It has not been characterized as producing a functional protein nor classified as a therapeutic target. RBM27 is an RNA-binding protein implicated in RNA metabolism and cellular processes, with some evidence suggesting roles in neurodevelopment and autism spectrum disorder through missense mutations[2]. POU4F3 is a transcription factor linked to sensory neuron development and hearing loss[4]. However, the readthrough transcript itself is not established as a drug target, receptor, or clinically actionable entity.
- Other names
- RBM27-POU4F3 readthroughRBM27-POU4F3
02
Mechanism of action
None described; no drugs target this locus.
03
Biological functions
Other (represents a readthrough RNA product; biological function uncharacterized)
04
Disease associations
Other (no direct association with disease independently; component genes may have disease links, e.g., RBM27 in autism candidate gene analysis, POU4F3 in hearing loss)
Beyond the preview
Go deeper on RBM27-POU4F3 readthrough (RBM27-POU4F3).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RBM27-POU4F3 readthrough (RBM27-POU4F3).